Hirsh Elhence

Articles by Hirsh Elhence

Hirsh ElhenceHypertrophic Cardiomyopathy | May 2, 2023
As novel therapeutic agents such as Mavacamten and Tafamidis are developed and become clinically useful for patients ...
Read More